← 產業報告目錄

Aquaculture Vaccines Market, By Species (Fish, Crustaceans, Mollusks, and Others), By Vaccine Type (Inactivated (Killed) Vaccines, Live Attenuated Vaccines, DNA Vaccines, and Others), By Pathogen Type (Bacterial Vaccines, Viral Vaccines, Parasitic Vaccines, and Others), By End User (Commercial Aquaculture Farms, Hatcheries, Research Institutes and Universities, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

出版商 Coherent Market Insights出版日期 2026-07-20頁數 250報告編號 CMR-fe604beed9

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global aquaculture vaccines market is estimated to be valued at USD 0.72 Bn in 2026 and is expected to reach USD 1.39 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033. The global aquaculture vaccines market is a significant aspect of the animal health industry as it caters to the need to sustainably grow fish and aquatic organisms, preventing the widespread infectious diseases. The demand for fish is escalating as aquaculture expands globally due to the diminishing populations of wild fish. However, such expansion has raised concerns about potential fish diseases. Aquaculture vaccines help in minimizing and prevention of disease outbreak in farmed species, thereby reducing costs and enhancing the growth and overall well-being of the farmed species. Vaccines have proved to be an excellent replacement for antibiotics, a less costly as well as an environment friendly solution for the prevention of bacterial, viral and parasitic diseases in farmed aquatic animals. Vaccines can be administered through injection, oral ingestion, or by immersion. These have seen substantial growth in popularity due to stringent policies of governments towards the reduction of antibiotic use. Market Dynamics The global aquaculture vaccines market is driven by the increasing production of aquaculture, growing global seafood demand, and the prevalence of aquatic disease. Furthermore, increasing restrictions over antibiotic use coupled with growing focus towards sustainable aquaculture practices is fueling up the market for vaccines. Besides this, development of recombinant, DNA based, adjuvant-based vaccines enhance vaccine efficiency and protection of major bacterial as well as viral diseases. However, a number of constraints are present in the market, such as high vaccine development and administration costs, limited availability of vaccines for several commercially farmed species, and inadequate veterinary infrastructure in developing regions. Nevertheless, expanding commercial aquaculture industry in Latin America, Africa as well as the Asia Pacific region, growing preference for antibiotic free seafood and innovation related to oral and thermo-stable vaccines are expected to provide lucrative opportunities for the market participants. Key Features of the Study • This report provides in-depth analysis of the global aquaculture vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global aquaculture vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, HIPRA, Virbac, Benchmark Holdings plc, Tecnovax S.A., Kyoto Biken Laboratories, Inc., and Nisseiken Co., Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global aquaculture vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aquaculture vaccines market Market Segmentation • Species Insights (Revenue, USD Bn, 2021 - 2033) o Fish o Crustaceans o Mollusks o Others • Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033) o Inactivated (Killed) Vaccines o Live Attenuated Vaccines o DNA Vaccines o Others • Pathogen Type Insights (Revenue, USD Bn, 2021 - 2033) o Bacterial Vaccines o Viral Vaccines o Parasitic Vaccines o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Commercial Aquaculture Farms o Hatcheries o Research Institutes and Universities o Others • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Zoetis Inc. o Merck Animal Health o Elanco Animal Health Incorporated o Phibro Animal Health Corporation o HIPRA o Virbac o Benchmark Holdings plc o Tecnovax S.A. o Kyoto Biken Laboratories, Inc. o Nisseiken Co., Ltd.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Aquaculture Vaccines Market, By Species  Global Aquaculture Vaccines Market, By Vaccine Type  Global Aquaculture Vaccines Market, By Pathogen Type  Global Aquaculture Vaccines Market, By End User  Global Aquaculture Vaccines Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Aquaculture Vaccines Market, By Species, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Fish  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Crustaceans  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mollusks  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Aquaculture Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Inactivated (Killed) Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Live Attenuated Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o DNA Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Aquaculture Vaccines Market, By Pathogen Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Bacterial Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Viral Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Parasitic Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Aquaculture Vaccines Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Commercial Aquaculture Farms  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hatcheries  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Research Institutes and Universities  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Aquaculture Vaccines Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Zoetis Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck Animal Health  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Elanco Animal Health Incorporated  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Phibro Animal Health Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o HIPRA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Virbac  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Benchmark Holdings plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Tecnovax S.A.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Kyoto Biken Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nisseiken Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Aquaculture Vaccines Market' - Global forecast to 2033
圖表清單 List of Tables & Figures
NA NA

提及公司

o Zoetis Inc.o Merck Animal Healtho Elanco Animal Health Incorporatedo Phibro Animal Health Corporationo HIPRAo Virbaco Benchmark Holdings plco Tecnovax S.A.o Kyoto Biken LaboratoriesInc.o Nisseiken Co.Ltd.

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們